logo
logo

Graviton Bio Science announced it raised $25 Million in an initial filing from an offering of $25 Million

Feb 14, 2024over 1 year ago

Amount Raised

$25 Million

New YorkBiotechnology

Company Information

Company

Graviton BioScience

Location

125 WEST END AVE.

New York, New York, United States

About

Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People